Sat.Mar 13, 2021 - Fri.Mar 19, 2021

article thumbnail

DeepVerge’s nanochip-based COVID breath test could be ready this year

pharmaphorum

DeepVerge has announced trial data showing its COVID-19 Microtox BT breath test can deliver accurate results in under 60 seconds, with a potential roll-out later this year if further tests support it. The company has already completed of the system that resembles a breathalyser in phase 1 and phase 2 studies with the SARS-CoV-2 virus in the safety of laboratories.

article thumbnail

AZ’s vaccine safety review shows ‘no evidence’ of an increased risk of blood clots

Pharma Times

Review included available safety data from over 17 million people vaccinated in the EU and UK with COVID-19 jab

Vaccines 150
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Saama, Oracle partner on integrated clinical trial technology

Outsourcing Pharma

Saamaâs range of Smart applications will be integrated with the Oracle Health Sciences Clinical One platform to help users accelerate drug development.

article thumbnail

Which pharmaceutical companies have the most drug patents in Poland?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Poland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Poland? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

IBM-led group wins German contract for digital vaccine passport

pharmaphorum

Germany has awarded a tender to a consortium led by IBM to develop a secure app that will provide a digital version of the country’s paper vaccine certificates. The €2.7 million ($3.2 million) contract covers the app and a backend system to allow for integration with IT systems operating in medical practices and vaccination centres, according to details published in the Official Journal of the EU.

Vaccines 144
article thumbnail

Finalists from last year’s CROY share their highlights

Pharma Times

Clinical Researcher of the Year – The Americas finalists reveal their positive experiences with the 2020 competition.

123
123

More Trending

article thumbnail

Which pharmaceutical companies have the most liquid dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most liquid dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most liquid dosed drugs…. The post Which pharmaceutical companies have the most liquid dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

The digital transformation of pharma’s physician engagement strategies

pharmaphorum

The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape – and one of the key ones is digital transformation in pharma. The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians.

article thumbnail

GSK, Medicago launch late-stage trial of plant-derived COVID-19 vaccine

Pharma Times

Vaccine candidate has previously been granted FDA fast track designation

Vaccines 136
article thumbnail

Reducing Patient Fallout: Transform How They Get and Stay on Medication

Drug Channels

Today’s guest post comes from Brian Haenni, Vice President of Hub Solutions at ConnectiveRx. Brian discusses the benefits of digital patient support services. To learn more about ConnectiveRx’s patient support capabilities, register for their April 14, 2021 webinar, Transforming the Patient Support Experience. Read on for Brian’s insights. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

52
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Argentina?

Drug Patent Watch

This chart shows the drugs with the most patents in Argentina. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Argentina? appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Regulators questioned integrity of Pfizer/BioNTech vaccine, leaked files show

pharmaphorum

European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following a cyberattack. As it conducted its analysis of the vaccine in December, the European Medicines Agency’s systems were targeted by unknown hackers. Following this, more than 40 megabytes of classified information from the agency’s review were published on the dark web and several journalists, including th

Vaccines 135
article thumbnail

Cambridge Sleep Sciences and Parkinson’s Concierge to test sleep device in Parkinson’s disease

Pharma Times

SleepHub device to be assessed in people with Parkinson's associated sleep issues

128
128
article thumbnail

Takeover of Spanish manufacturer STE Tecpharm, S. L. – Romaco expands processing business

Pharma Mirror

With the acquisition of the Spanish manufacturer STE Tecpharm, S. L., Romaco strengthens its position as a turnkey supplier of processing technologies. In particular, Tecpharm’s patented drum coaters will complement Romaco Innojet’s granulation and fluid bed technologies. On 18 March 2021, Romaco Holding GmbH announced the purchase of the Spanish manufacturer of processing technology STE Tecpharm, S.

52
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

New patent expiration for Recordati Rare drug NEOPROFEN

Drug Patent Watch

Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two suppliers. There are three patents…. The post New patent expiration for Recordati Rare drug NEOPROFEN appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Could a smartphone cough app stop future pandemics?

pharmaphorum

A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea a step further and use them to detect future pandemics, reports Richard Staines. . The pandemic has seen a plethora of digital tools emerge to help manage patients remotely, with the ubiquitous use of smartphone technology allowing medics to monitor patients’ vital signs without risky face-to-face contact.

122
122
article thumbnail

UK and EU regulators reaffirm the safety of AZ/Oxford Uni’s COVID-19 vaccine

Pharma Times

MHRA and EMA conclude the vaccine's benefits continue to outweigh risks

Vaccines 130
article thumbnail

DarshanTalks: Marketing & Medical Affairs – March 9, 2021

Pharma Marketing Network

[link]. Marketing and medical affairs are often perceived as being separate. What happens when drug companies market their own products? Join Darshan Kulkarni as he talks with guest Dr. Stephen Towers about the intersection between marketing and medical affairs. Darshan and Stephen also discuss how medical affairs can inform marketing efforts. The post DarshanTalks: Marketing & Medical Affairs </br>– March 9, 2021 appeared first on Pharma Marketing Network.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

New patent for Teva Branded drug PROAIR DIGIHALER

Drug Patent Watch

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Protected: Using AI to make a big impact for emerging and mid-sized biopharma companies

pharmaphorum

This content is password protected. To view it please enter your password below: Password: The post Protected: Using AI to make a big impact for emerging and mid-sized biopharma companies appeared first on.

115
115
article thumbnail

EU authorisation for XPhyto’s rapid COVID-19 PCR test

Pharma Times

PCR-based test has a sample collection to result time of 25 minutes

117
117
article thumbnail

DZNE and Eisai Enter Into Research Collaboration Agreement Aiming for Novel Drug Discovery for Neurodegenerative Disorders

Pharma Mirror

Deutsches Zentrum fur Neurodegenerative Erkrankungen and Eisai Co., Ltd. today announced that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders including Alzheimer’s disease (AD) which modulate immune competence in neurons and glia cells. DZNE is a world-leading interdisciplinary public research organization constituted with ten research sites in Germany that investigates methods for prevention, dia

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

New patent for Teva Branded drug PROAIR RESPICLICK

Drug Patent Watch

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Novavax confirms efficacy of COVID-19 jab against UK variant

pharmaphorum

A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the virus. . The phase 3 trial – which takes Novavax’ NVX?CoV2373 shot a step closer to approval – also found that it was 100% effective in preventing severe COVID-19.

Vaccines 111
article thumbnail

Sanofi, Regeneron’s Libtayo improves survival in cervical cancer patients

Pharma Times

Phase III trial stopped early for positive result on overall survival

117
117
article thumbnail

Cannabis Isn’t as Safe as You Think

Pharma Mirror

After over a half-century of lobbying, it seems that cannabis prohibition may finally come to an end at the federal level. For a lot of Americans, many of whom have seen their states legalize cannabis and marijuana products to varying degrees, this may seem like a natural course of events for the harmless but controversial plant. Except, cannabis isn’t entirely harmless.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

New patent for Amicus Theraps drug GALAFOLD

Drug Patent Watch

Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Theraps Us and is included in one NDA. There are twenty-one patents protecting this drug. This drug…. The post New patent for Amicus Theraps drug GALAFOLD appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

EMA review finds AZ COVID-19 vaccine “safe and effective”

pharmaphorum

An EMA advisory committee’s review of AstraZeneca’s COVID-19 has concluded that there is no increase in the overall risk of blood clots with this vaccine. The chair of the Pharmacovigilance Risk Assessment Committee (PRAC), Dr Sabine Straus, told a press briefing today that the vaccine “is safe and effective and its benefits continue to be far greater than its risks.”.

Vaccines 105
article thumbnail

ICR’s ‘resistance-busting’ drug advances into Phase I trial

Pharma Times

EP0042 is a dual-inhibitor drug designed to block the activity of two cancer-driving proteins

101
101
article thumbnail

NEW: The 2021 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

Drug Channels

I am pleased to announce our new 2021 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: The Latest Trends for U.S. Drug Pricing, Reimbursement, and Patient Costs (press release) We’re offering special discounted pricing if you order before March 28, 2021.

article thumbnail

New patent for Teva Pharm drug ARMONAIR DIGIHALER

Drug Patent Watch

Annual Drug Patent Expirations for ARMONAIR+DIGIHALER Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-one…. The post New patent for Teva Pharm drug ARMONAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.

52